Real Life of Aflibercept in France in Patients Refractory to Ranibizumab: Observational Study in Wet AMD

Clinical trial NCT02321241 · COMPLETED

Trial details

NCT number: NCT02321241
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Wet Macular Degeneration

Start date: 2016-02-01
Primary completion: 2017-01-18
Enrollment: 236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.